![Satoshi Konagai](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Satoshi Konagai
Direktor/Vorstandsmitglied bei Solu Therapeutics
Aktive Positionen von Satoshi Konagai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Private Equity Investor | 01.10.2020 | - |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Direktor/Vorstandsmitglied | 01.12.2021 | - |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Direktor/Vorstandsmitglied | - | - |
Karriereverlauf von Satoshi Konagai
Ehemalige bekannte Positionen von Satoshi Konagai
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTELLAS PHARMA INC. | Corporate Officer/Principal | 01.04.2015 | 31.10.2020 |
Ausbildung von Satoshi Konagai
Kyoto University | Graduate Degree |
University of Massachusetts | Masters Business Admin |
Statistik
International
Vereinigte Staaten | 5 |
Japan | 3 |
Operativ
Director/Board Member | 2 |
Private Equity Investor | 1 |
Graduate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ASTELLAS PHARMA INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Astellas Venture Management LLC
![]() Astellas Venture Management LLC Investment ManagersFinance Astellas Venture Management LLC (Astellas Venture Management) is a venture capital subsidiary of Astellas Pharma Inc founded in 2000. The firm is headquartered in San Francisco, California. | Finance |
Cleave Therapeutics, Inc.
![]() Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA. | Health Technology |
Solu Therapeutics
![]() Solu Therapeutics Pharmaceuticals: MajorHealth Technology Solu Therapeutics is an American precision-medicine company focused on developing therapeutics to eliminate disease-driving cells in cancer, immunology, and autoimmunity. The company is located in the US. The company's proprietary cytotoxicity targeting chimera (cytac) platform and drug candidates, licensed from GSK, unlock antibody-intractable cell surface targets, providing the capability to develop next-generation medicines that harness the power of biologics with the vast target binding space of small molecules. | Health Technology |
- Börse
- Insiders
- Satoshi Konagai
- Erfahrung